Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid beta-oxidation defects: phenotype/metabolite correlations (Q44123147)

30 November 2017

title

Quantitative fibroblast acylcarnitine profiles in mitochondrial fatty acid beta-oxidation defects: phenotype/metabolite correlations (English)

1 reference

30 November 2017

0 references

4

1 reference

30 November 2017

Keow Giak Sim

1

1 reference

30 November 2017

Kevin Carpenter

series ordinal

2

1 reference

30 November 2017

Judith Hammond

series ordinal

3

1 reference

30 November 2017

Bridget Wilcken

series ordinal

5

1 reference

30 November 2017

publication date

1 August 2002

1 reference

Molecular Genetics and Metabolism

30 November 2017

published in

1 reference

30 November 2017

volume

76

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

327-334

1 reference

Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Common MCAD mutation in a healthy parent of two affected siblings

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Inheritance of the S113L mutation within an inbred family with carnitine palmitoyltransferase enzyme deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Acylcarnitine profiles in fibroblasts from patients with respiratory chain defects can resemble those from patients with mitochondrial fatty acid beta-oxidation disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Carnitine-acylcarnitine translocase deficiency--a mild phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Analysis of carnitine esters by radio-high performance liquid chromatography in cultured skin fibroblasts from patients with mitochondrial fatty acid oxidation disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Recent developments in the investigation of inherited metabolic disorders using cultured human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Lethal neonatal multiorgan deficiency of carnitine palmitoyltransferase II

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Muscular carnitine palmitoyltransferase II deficiency in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

"Adult" form of muscular carnitine palmitoyltransferase II deficiency: manifestation in a 2-year-old child

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Mitochondrial trifunctional protein deficiency associated with recurrent myoglobinuria in adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Clinical and biochemical variation and family studies in the multiple acyl-CoA dehydrogenation disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Lipid storage myopathy due to glutaric aciduria type II: treatment of a potentially fatal myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Lipid storage myopathy in multiple acyl-CoA dehydrogenase deficiency: an adult case

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Medium chain acyl-CoA dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Medium-chain acyl-coenzyme A dehydrogenase deficiency: clinical course in 120 affected children.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Outcome of medium chain acyl-CoA dehydrogenase deficiency after diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that res

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

Elucidation of the mechanism by which (+)-acylcarnitines inhibit mitochondrial fatty acid transport

1 reference

https://api.crossref.org/works/10.1016%2FS1096-7192%2802%2900112-9

7 January 2021

10.1016/S1096-7192(02)00112-9

Identifiers

DOI

1 reference

30 November 2017

1 reference